BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

624 related articles for article (PubMed ID: 24668102)

  • 1. Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial.
    Phoa KN; van Vilsteren FG; Weusten BL; Bisschops R; Schoon EJ; Ragunath K; Fullarton G; Di Pietro M; Ravi N; Visser M; Offerhaus GJ; Seldenrijk CA; Meijer SL; ten Kate FJ; Tijssen JG; Bergman JJ
    JAMA; 2014 Mar; 311(12):1209-17. PubMed ID: 24668102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency ablation in Barrett's esophagus with dysplasia.
    Shaheen NJ; Sharma P; Overholt BF; Wolfsen HC; Sampliner RE; Wang KK; Galanko JA; Bronner MP; Goldblum JR; Bennett AE; Jobe BA; Eisen GM; Fennerty MB; Hunter JG; Fleischer DE; Sharma VK; Hawes RH; Hoffman BJ; Rothstein RI; Gordon SR; Mashimo H; Chang KJ; Muthusamy VR; Edmundowicz SA; Spechler SJ; Siddiqui AA; Souza RF; Infantolino A; Falk GW; Kimmey MB; Madanick RD; Chak A; Lightdale CJ
    N Engl J Med; 2009 May; 360(22):2277-88. PubMed ID: 19474425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eliminating a need for esophagectomy: endoscopic treatment of Barrett esophagus with early esophageal neoplasia.
    Lada MJ; Watson TJ; Shakoor A; Nieman DR; Han M; Tschoner A; Peyre CG; Jones CE; Peters JH
    Semin Thorac Cardiovasc Surg; 2014; 26(4):274-84. PubMed ID: 25837538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cost-effectiveness of radiofrequency ablation for Barrett's esophagus with low-grade dysplasia: results from a randomized controlled trial (SURF trial).
    Phoa KN; Rosmolen WD; Weusten BLAM; Bisschops R; Schoon EJ; Das S; Ragunath K; Fullarton G; DiPietro M; Ravi N; Tijssen JGP; Dijkgraaf MGW; Bergman JJGHM;
    Gastrointest Endosc; 2017 Jul; 86(1):120-129.e2. PubMed ID: 27956164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Durability of radiofrequency ablation in Barrett's esophagus with dysplasia.
    Shaheen NJ; Overholt BF; Sampliner RE; Wolfsen HC; Wang KK; Fleischer DE; Sharma VK; Eisen GM; Fennerty MB; Hunter JG; Bronner MP; Goldblum JR; Bennett AE; Mashimo H; Rothstein RI; Gordon SR; Edmundowicz SA; Madanick RD; Peery AF; Muthusamy VR; Chang KJ; Kimmey MB; Spechler SJ; Siddiqui AA; Souza RF; Infantolino A; Dumot JA; Falk GW; Galanko JA; Jobe BA; Hawes RH; Hoffman BJ; Sharma P; Chak A; Lightdale CJ
    Gastroenterology; 2011 Aug; 141(2):460-8. PubMed ID: 21679712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasia.
    Kahn A; Al-Qaisi M; Kommineni VT; Callaway JK; Boroff ES; Burdick GE; Lam-Himlin DM; Temkit M; Vela MF; Ramirez FC
    Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29036431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients With Barrett's Esophagus and Confirmed Low-Grade Dysplasia.
    Small AJ; Araujo JL; Leggett CL; Mendelson AH; Agarwalla A; Abrams JA; Lightdale CJ; Wang TC; Iyer PG; Wang KK; Rustgi AK; Ginsberg GG; Forde KA; Gimotty PA; Lewis JD; Falk GW; Bewtra M
    Gastroenterology; 2015 Sep; 149(3):567-76.e3; quiz e13-4. PubMed ID: 25917785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry.
    Ganz RA; Overholt BF; Sharma VK; Fleischer DE; Shaheen NJ; Lightdale CJ; Freeman SR; Pruitt RE; Urayama SM; Gress F; Pavey DA; Branch MS; Savides TJ; Chang KJ; Muthusamy VR; Bohorfoush AG; Pace SC; DeMeester SR; Eysselein VE; Panjehpour M; Triadafilopoulos G;
    Gastrointest Endosc; 2008 Jul; 68(1):35-40. PubMed ID: 18355819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late Recurrence of Barrett's Esophagus After Complete Eradication of Intestinal Metaplasia is Rare: Final Report From Ablation in Intestinal Metaplasia Containing Dysplasia Trial.
    Cotton CC; Wolf WA; Overholt BF; Li N; Lightdale CJ; Wolfsen HC; Pasricha S; Wang KK; Shaheen NJ;
    Gastroenterology; 2017 Sep; 153(3):681-688.e2. PubMed ID: 28579538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up.
    Fleischer DE; Overholt BF; Sharma VK; Reymunde A; Kimmey MB; Chuttani R; Chang KJ; Lightdale CJ; Santiago N; Pleskow DK; Dean PJ; Wang KK
    Gastrointest Endosc; 2008 Nov; 68(5):867-76. PubMed ID: 18561930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system).
    Sharma VK; Kim HJ; Das A; Dean P; DePetris G; Fleischer DE
    Endoscopy; 2008 May; 40(5):380-7. PubMed ID: 18459074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes of patients with Barrett's esophagus and high-grade dysplasia or early cancer treated with endoluminal therapies with intention to complete eradication.
    Guarner-Argente C; Buoncristiano T; Furth EE; Falk GW; Ginsberg GG
    Gastrointest Endosc; 2013 Feb; 77(2):190-9. PubMed ID: 23317687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversies in Barrett esophagus.
    Dunbar KB; Spechler SJ
    Mayo Clin Proc; 2014 Jul; 89(7):973-84. PubMed ID: 24867396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radiofrequency ablation for Barret's esophagus].
    Fraga M; Doerig C; Dorta G; Nichita C
    Rev Med Suisse; 2013 Sep; 9(396):1572-6. PubMed ID: 24066464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvage cryotherapy after failed radiofrequency ablation for Barrett's esophagus-related dysplasia is safe and effective.
    Sengupta N; Ketwaroo GA; Bak DM; Kedar V; Chuttani R; Berzin TM; Sawhney MS; Pleskow DK
    Gastrointest Endosc; 2015 Sep; 82(3):443-8. PubMed ID: 25887715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
    Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R
    Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive factors for initial treatment response after circumferential radiofrequency ablation for Barrett's esophagus with early neoplasia: a prospective multicenter study.
    van Vilsteren FG; Alvarez Herrero L; Pouw RE; Schrijnders D; Sondermeijer CM; Bisschops R; Esteban JM; Meining A; Neuhaus H; Parra-Blanco A; Pech O; Ragunath K; Rembacken B; Schenk BE; Visser M; ten Kate FJ; Meijer SL; Reitsma JB; Weusten BL; Schoon EJ; Bergman JJ
    Endoscopy; 2013 Jul; 45(7):516-25. PubMed ID: 23580412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stepwise radical endoscopic resection versus radiofrequency ablation for Barrett's oesophagus with high-grade dysplasia or early cancer: a multicentre randomised trial.
    van Vilsteren FG; Pouw RE; Seewald S; Alvarez Herrero L; Sondermeijer CM; Visser M; Ten Kate FJ; Yu Kim Teng KC; Soehendra N; Rösch T; Weusten BL; Bergman JJ
    Gut; 2011 Jun; 60(6):765-73. PubMed ID: 21209124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II).
    Phoa KN; Pouw RE; Bisschops R; Pech O; Ragunath K; Weusten BL; Schumacher B; Rembacken B; Meining A; Messmann H; Schoon EJ; Gossner L; Mannath J; Seldenrijk CA; Visser M; Lerut T; Seewald S; ten Kate FJ; Ell C; Neuhaus H; Bergman JJ
    Gut; 2016 Apr; 65(4):555-62. PubMed ID: 25731874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiofrequency Ablation of Barrett's Esophagus: Efficacy, Complications, and Durability.
    Visrodia K; Zakko L; Wang KK
    Gastrointest Endosc Clin N Am; 2017 Jul; 27(3):491-501. PubMed ID: 28577770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.